Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave to Supply Invader System to University of Wisconsin

NEW YORK, Feb 6 – Third Wave Technologies said Tuesday it would supply its Invader SNP detection and gene expression system to the University of Wisconsin, Madison in exchange for rights to commercialize certain discoveries for research, diagnostic, or therapeutic purposes.

" This is yet another initiative to expand the reach of our platform to identify valuable targets that may be useful in identifying the genetic cause of diseases and therapeutic candidates for treatment," Lance Fors, Third Wave CEO, said in a statement.

Fors said he expects the collaboration to help speed up discoveries linking genetics to disease.

Third Wave’s other deals include agreements with Glaxo-SmithKline, Novartis, Pfizer, and the Sanger Center.

The company’s initial public offering is expected to take place by the middle of February.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.